Labor pain
Conditions
Interventions
Group 0.0625% ropivacaine + 0.4 µg/ml dexmedetomidine:Drug Formulation
Group 0.0625% ropivacaine + 0.4 µg/ml sufentanil:Drug Formulation
Sponsors
Zhejiang Xiaoshan Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1.Parturients aged 18 to 40 years; 2.ASA physical status; 3.Height >= 150 cm and weight = 37 weeks; 5.Cephalic presentation; 6.Visual Analog Scale (VAS) score > 3 (on a scale of 0 = no pain to 10 = worst possible pain);
Exclusion criteria
Exclusion criteria: 1.Contraindications to neuraxial anesthesia; 2.Known allergy to anesthetics, sufentanil, or dexmedetomidine; 3.Bradycardia; 4.Multiple gestation; 5.Preeclampsia; 6.Fetal abnormalities; 7.Refusal to provide informed consent; 8.Other conditions: history of cesarean section, long-term use of sedatives or analgesics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Umbilical arterial blood gas analysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS) score;Mode of delivery;Adverse reactions;The condition of newborns; | — |
Countries
China
Contacts
Public ContactYu Jing, Song Congzhong, Xu Yang, Ni Lifeng, Wang Qingfu, Liu Chaohui, Peng Song
Zhejiang Xiaoshan Hospital
Outcome results
None listed